Koninklijke Philips vs West Pharmaceutical Services
Koninklijke Philips (PHG), health care, and West Pharmaceutical Services (WST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Koninklijke Philips and West Pharmaceutical Services are valued at about the same: $29.2B and $28.8B. Koninklijke Philips trades at 26.0 times earnings and West Pharmaceutical Services at 46.5; operating margins in their latest fiscal years were 7.98% and 19.0%. Over the past year Koninklijke Philips's share price has moved +9.64% and West Pharmaceutical Services's +60.6%.
Key facts
- Koninklijke Philips market value
- $29.2B
- West Pharmaceutical Services market value
- $28.8B
- Koninklijke Philips P/E
- 26.0
- West Pharmaceutical Services P/E
- 46.5
- Koninklijke Philips revenue
- $19.8BFY to 2025-12-31
- West Pharmaceutical Services revenue
- $3.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Koninklijke Philips | West Pharmaceutical Services |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $29.2Bhigher | $28.8Blower |
| Revenue | $19.8Bhigher | $3.1Blower |
| Earnings | $993Mhigher | $493.7Mlower |
| Employees | 63,909higher | 10,000lower |
| Total assets | $29.9Bhigher | $4.3Blower |
| Valuation | ||
| P/E | 26.0lower | 46.5higher |
| P/S | 1.5lower | 9.4higher |
| P/B | — | 9.7 |
| Dividend yield | — | 0.21% |
| Profitability | ||
| Operating margin | 7.98%lower | 19.0%higher |
| Balance sheet | ||
| Net assets | $12.2Bhigher | $3.2Blower |
| Total liabilities | $17.7Bhigher | $1.1Blower |
| Total debt | $9Bhigher | $202.8Mlower |
| Cash on hand | $3.1Bhigher | $791.3Mlower |
| Price change | ||
| Today | -0.83%higher | -0.88%lower |
| 1 year | +9.64%lower | +60.6%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Koninklijke Philips only (4)
- Pat English1.2%
- Sarah Ketterer0.8%
- Charles Brandes (founder)0.4%
- Richard Pzena<0.1%
West Pharmaceutical Services only (3)
- Bill Gates0.5%
- Brandon Haley0.2%
- Ron Baron0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns PHG · Who owns WST
More on Koninklijke Philips
More on West Pharmaceutical Services
Further comparisons
Koninklijke Philips against its closest peers
West Pharmaceutical Services against its closest peers
Learn
Questions and answers
Which is bigger, Koninklijke Philips or West Pharmaceutical Services?
By market value, Koninklijke Philips is the larger: $29.2B against $28.8B for West Pharmaceutical Services. By revenue in its latest fiscal year, Koninklijke Philips is the larger: $19.8B against $3.1B for West Pharmaceutical Services.
Which has the higher P/E ratio?
West Pharmaceutical Services: 46.5, against 26.0 for Koninklijke Philips. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
West Pharmaceutical Services: 19.0%, against 7.98% for Koninklijke Philips. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Koninklijke Philips: $9B, against $202.8M for West Pharmaceutical Services. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Koninklijke Philips and West Pharmaceutical Services?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Koninklijke Philips and 3 hold West Pharmaceutical Services.
Cite this page
Funkfolio, “Koninklijke Philips vs West Pharmaceutical Services”, data as of 17 November 2026. https://funkfolio.com/compare/phg-vs-wst
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.